| ||
| Agennix Announces New Data From Talactoferrin Phase II Trials in ... Rajesh Malik, M.D., Chief Medical Officer of Agennix, said: "Treatment options for non-small cell lung cancer patients with refractory disease are often ... www.pr-inside.com/agennix-announces-new-data-from-talacto... | ||
| New Study Released Today Showed Patients With Deadly Form of Lung ... About Non-Small Cell Lung Cancer (NSCLC). Globally, lung cancer is the ... You will have regular blood tests before and during your treatment with ALIMTA. ... ca.biz.yahoo.com/prnews/110605/de06340.html?.v=1 |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment